Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pulmonary edema/ödem
Länken sparas på Urklipp
Sida 1 från 91 resultat
Systems and methods for monitoring pulmonary edema dynamics
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This document pertains generally to medical systems, devices, or methods, and more particularly, but not by way of limitation, to systems and methods for monitoring pulmonary edema.
BACKGROUND
One hallmark of heart failure (HF) in a subject is congestion, more commonly referred to as
Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
Applicant claims priority under 35 U.S.C. .sctn.119 of German Application No. 103 52 692.7 filed Nov. 12, 2003. Applicant also claims priority under 35 U.S.C. .sctn.365 of PCT/EP2004/012363 filed Nov. 2, 2004. The international application under PCT article
Treatment of acute pulmonary edema with arginine esters
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to novel therapeutic composition, particularly useful against acute pulmonary edema, shock caused by bacterial endotoxins, hyperfibrinolysis and anaphylactic shock. More specifically, the present invention relates to esters of L-arginine.
Many esters of L-arginine are
System and method for detecting heart failure and pulmonary edema based on ventricular end-diastolic pressure using an implantable medical device
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The invention generally relates to implantable medical devices, such as pacemakers or implantable cardioverter/defibrillators (ICDs), and in particular to techniques for measuring left ventricular end diastolic pressure (LV EDP) and for detecting the onset of heart failure and
Method and apparatus to monitor pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to medical devices, and more particularly, to medical devices that sense cardiac electrical signals.
BACKGROUND
Heart failure refers to the heart's inability to keep up with the demands made upon it. Congestive heart failure refers to an inability of the heart
Method and apparatus for detecting pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This application relates generally to medical applications, and to detection of acute decompensation and pulmonary-related conditions.
BACKGROUND
The health of many patients who have had a heart attack may deteriorate over time due to progressive heart failure. For example, a heart
Enhancements to the detection of pulmonary edema when using transthoracic impedance
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATION
This patent application is related to U.S. patent application, entitled "IMPROVED SENSITIVITY AND SPECIFICITY OF PULMONARY EDEMA DETECTION WHEN USING TRANSTHORACIC IMPEDANCE," filed even date herewith Ser. No. 11/126,723 which is hereby incorporated by
Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATION
This patent application is related to U.S. Pat. Application Ser. No. 11/126,689, entitled "ENHANCEMENTS TO THE DETECTION OF PULMONARY EDEMA WHEN USING TRANSTHORACIC IMPEDANCE," filed May 11, 2005, which is hereby incorporated by reference in its
Enhancements to the detection of pulmonary edema when using transthoracic impedance
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This patent document pertains generally to medical systems, devices, and methods, and more particularly, but not by way of limitation, to medical systems, devices, and methods for the detection of pulmonary edema using thoracic impedance.
BACKGROUND
Variations in how much fluid is
Systems and methods for treating pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present disclosure relates generally to systems and methods for treating pulmonary edema.
BACKGROUND
The lymphatic system is part of the circulatory system in conjunction with the arterial and venous systems. A primary function of the lymphatic system is to drain excessive interstitial
Method and implantable medical device for assessing a degree of pulmonary edema of a patient
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to implantable medical devices, such as cardiac pacemakers and implantable cardioverter/defibrillators, and in particular to an improved method and an implantable medical device for assessing a degree of
System and method for identifying a potential cause of pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application is related to U.S. Pat. No. 7,676,260 Ser. No. 11/740,733, filed Apr. 26, 2007, titled "Implantable Cardiac Stimulation Device That Monitors Progression and Regression of Heart Disease Responsive to Differences in Averaged Electrograms and
Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Methods and compositions are provided for gene therapy for pulmonary edema by the transfer of Na,K-ATPase subunit genes to lung epithelial cells for the purpose of increasing levels of Na, K-ATPase in vivo.
Cardiogenic and non-cardiogenic pulmonary edema affect millions
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
INOmax.RTM., (nitric oxide) for inhalation is an approved drug product for the treatment of term and near-term (>34 weeks gestation) neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension.
The use of
Methods and systems that use implanted posture sensor to monitor pulmonary edema
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is related to the following commonly assigned U.S. Patent Applications, each of which is incorporated herein by references: U.S. patent application Ser. No. 11/863,516, entitled "Use of Cardiogenic Impedance Waveform Morphology to Analyze
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
